Idexx Laboratories LPD — Goodwill increased by 12.1% to $15.12M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.1%, from $13.48M to $15.12M.
An increase suggests recent strategic acquisitions, while a decrease may indicate impairment charges due to declining business performance or market conditions.
This represents the excess of the purchase price over the fair value of identifiable net assets acquired in business com...
Commonly reported by life sciences and diagnostic companies as part of segment-level balance sheet disclosures following M&A activity.
idxx_segment_lpd_goodwill| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $13.70M | $13.88M | $14.99M | $13.48M | $15.12M |
| QoQ Change | — | +1.3% | +8.0% | -10.0% | +12.1% |
| YoY Change | — | +1.3% | +8.0% | -10.0% | +12.1% |